¿Qué ETFs tienen en cartera GLENMARK.NS?
Glenmark Pharmaceuticals Limited · Healthcare · Drug Manufacturers - Specialty & Generic · IN — 7 ETFs que lo tienen, valorado en $112.7M en 4.80M participaciones.
Posiciones a fecha de Aug 26, 2026 — fechas de reporte de cartera del proveedor de datos; no son posiciones en tiempo real.
| # | ETF | Peso | Acciones | Value | AUM del ETF | Categoría | Hoy | |
|---|---|---|---|---|---|---|---|---|
| 1 | VEXC Vanguard Emerging Markets Ex-China ETF | 0.04% | 4.91K | $114.9K | $257.8M | Emerging Markets | +0.59% | |
| 2 | SCHE Schwab Emerging Markets Equity ETF | 0.03% | 173.51K | $4.3M | $12.91B | Emerging Markets | +0.46% | |
| 3 | VWO Vanguard FTSE Emerging Markets ETF | 0.03% | 2.03M | $47.5M | $162.30B | Emerging Markets | +0.59% | |
| 4 | VSGX Vanguard ESG International Stock ETF | 0.01% | 28.44K | $665.8K | $6.50B | Developed Markets | +0.10% | |
| 5 | VEU Vanguard FTSE All-World ex-US ETF | 0.01% | 336.08K | $7.9M | $95.90B | Developed Markets | +0.06% | |
| 6 | VXUS Vanguard Total International Stock ETF | 0.01% | 2.11M | $49.3M | $646.20B | Developed Markets | +0.13% | |
| 7 | VT Vanguard Total World Stock ETF | 0.00% | 125.16K | $2.9M | $97.90B | Developed Markets | +0.44% |
La cobertura refleja las carteras de ETFs cargadas en nuestra base de datos; es posible que los fondos muy pequeños aún no hayan sido procesados. Market data delayed approximately 15–20 minutes unless otherwise indicated.